Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: ASM
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
"Cliffs shares are public knowledge."
This statement is true, but what that PUBLIC KNOWLEDGE confirms is that Cliff owns NO SHARES of PTSC.
Per the last filing it was reported as follows. Please read footnote no. 3! Since this filing, there have been NO filings by Cliff indicating that he's exercised any options thus far, so technically, he owns no PTSC shares.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS, DIRECTORS AND MANAGEMENT
The following table sets forth, as of December 16, 2011, the stock ownership of each of our executive officers and directors, of all our executive officers and directors as a group, and of each person known to us to be a beneficial owner of 5% or more of our Common Stock. In general, “Beneficial Ownership” refers to shares that an individual or entity has the power to vote or dispose of, and any rights to acquire common stock that are currently exercisable or will become exercisable within 60 days of December 16, 2011. The number of shares of Common Stock outstanding as of December 16, 2011, was 406,215,073. Except as otherwise noted, each person listed below is the sole beneficial owner of the shares and has sole investment and voting power over such shares. Each individual’s address is 701 Palomar Airport Road, Suite 170, Carlsbad, California 92011-1045.
|
Name
|
Amount & Nature of
Beneficial Ownership
|
Percent of Class
|
|
Gloria H. Felcyn, CPA
|
1,259,700 (1)
|
*
|
|
Carlton M. Johnson, Jr.
|
975,000 (2)
|
*
|
|
Clifford L. Flowers
|
900,000 (3)
|
*
|
|
All directors & officers as a group (3 persons)
|
3,134,700 (4)
|
0.77%
|
*Less than 1%
|
(1)
|
Includes 450,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of December 16, 2011.
|
|
(2)
|
Includes 450,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of December 16, 2011.
|
|
(3)
|
Represents shares issuable upon the exercise of outstanding stock options exercisable within 60 days of December 16, 2011.
|
|
(4)
|
Includes 1,800,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of December 16, 2011.
|
5 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply